Get the Stockscreener App
25.36
0.04%
-0.01
Amphastar Pharmaceuticals Inc stock is traded at $25.36, with a volume of 355.78K.
It is down -0.04% in the last 24 hours and up +6.87% over the past month.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$25.37
Open:
$25.54
24h Volume:
355.78K
Relative Volume:
0.81
Market Cap:
$1.18B
Revenue:
$722.68M
Net Income/Loss:
$134.71M
P/E Ratio:
9.4981
EPS:
2.67
Net Cash Flow:
$109.94M
1W Performance:
-3.83%
1M Performance:
+6.87%
6M Performance:
+1.16%
1Y Performance:
-42.48%
1-Day Range:
$24.92
$26.01
1-Week Range:
$24.92
$26.57
52-Week Range:
$20.39
$46.43
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
25.36 | 1.17B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Upgrade | Needham | Hold → Buy |
| May-12-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-04-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Will Amphastar Pharmaceuticals Inc. (29A) stock boost dividends furtherJuly 2025 Rallies & Safe Swing Trade Setup Alerts - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock recover faster than industry2025 Geopolitical Influence & Proven Capital Preservation Methods - newser.com
Amphastar Pharmaceuticals : Q3 Financial Results (AMP 2025 Q3 Earnings Release FINAL) - MarketScreener
How Amphastar Pharmaceuticals Inc. stock reacts to oil pricesQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
Will Amphastar Pharmaceuticals Inc. stock recover faster than marketWeekly Trend Recap & Stock Portfolio Risk Control - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leaderJuly 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock is listed among top recommendationsJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
How risky is Amphastar Pharmaceuticals Inc. (29A) stock compared to peersWeekly Investment Summary & Technical Pattern Based Signals - newser.com
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder value2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock good for long term investingJuly 2025 Movers & Daily Stock Trend Reports - newser.com
What momentum shifts mean for Amphastar Pharmaceuticals Inc.Bear Alert & AI Powered Buy/Sell Recommendations - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.Quarterly Trade Summary & Weekly Chart Analysis and Trade Guides - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock trading at attractive multiplesJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Floyd Petersen Sells 16,679 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat
Campbell & CO Investment Adviser LLC Sells 23,356 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Why Amphastar Pharmaceuticals Inc. stock remains resilientJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Is Amphastar Pharmaceuticals Inc. stock supported by strong cash flowsGap Down & Stock Timing and Entry Methods - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock a buy for dividend portfoliosWeekly Trade Report & High Yield Equity Trading Tips - newser.com
Can Amphastar Pharmaceuticals Inc. stock maintain growth trajectoryWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Amphastar Pharmaceuticals Inc Stock (AMPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Petersen Floyd F. | Director |
Nov 13 '25 |
Sale |
26.49 |
16,679 |
441,837 |
75,531 |
6.17%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):